Triiodothyronine (T3) levels fluctuate in response to ambient temperature rather than nutritional status in a wild tropical ungulate

Animals can employ a range of physiological mechanisms in response to unpredictable changes within their environment, such as changes in food availability and human disturbances. For example, impala exhibit higher faecal glucocorticoid metabolite (FGM) levels—indicative of physiological stress—in response to low food quality and higher human disturbance. In this study, we measured faecal triiodothyronine (T3) metabolite (FTM) levels in 446 wild impala from 2016 to 2018 to test the hypothesis that environmental and human disturbances would affect their physiological status. We also validated a faecal thyroid hormone assay. T3 levels mainly regulate metabolic rate and drive thermoregulation—increasing with colder temperatures. We predicted that individuals would have lower FTM levels, indicative of poor physiological status, (i) when food quality was poor, (ii) when ambient temperature (Ta) was high, (iii) in areas of high human disturbance (due to food competition with livestock) and (iv) when FGM levels were high. Interestingly, we found that Ta was the most important predictor of FTM—FTM levels decreased by 70% from lowest to highest Ta—and food quality and human disturbance only influenced FTM levels when Ta was accounted for. FTM levels also tended to increase with increasing FGM levels, opposite our predictions. Our results suggest that food quality and availabilitymay only partially influence FTM levels and that fluctuations in Ta are a significant driver of FTM levels in a wild tropical ungulate. Given that thyroid hormones are primarily responsible for regulating metabolic rate, they may be better indicators of how wild animals metabolically and energetically respond to environmental factors and only indicate poor nutritional status in extreme cases. glucocorticoid, impala, Serengeti, stress, thyroid hormones, validationpublishedVersio

A global research priority agenda to advance public health responses to fatty liver disease

Background & aims An estimated 38% of adults worldwide have non-alcoholic fatty liver disease (NAFLD). From individual impacts to widespread public health and economic consequences, the implications of this disease are profound. This study aimed to develop an aligned, prioritised fatty liver disease research agenda for the global health community. Methods Nine co-chairs drafted initial research priorities, subsequently reviewed by 40 core authors and debated during a three-day in-person meeting. Following a Delphi methodology, over two rounds, a large panel (R1 n = 344, R2 n = 288) reviewed the priorities, via Qualtrics XM, indicating agreement using a four-point Likert-scale and providing written feedback. The core group revised the draft priorities between rounds. In R2, panellists also ranked the priorities within six domains: epidemiology, models of care, treatment and care, education and awareness, patient and community perspectives, and leadership and public health policy. Results The consensus-built fatty liver disease research agenda encompasses 28 priorities. The mean percentage of ‘agree’ responses increased from 78.3 in R1 to 81.1 in R2. Five priorities received unanimous combined agreement (‘agree’ + ‘somewhat agree’); the remaining 23 priorities had >90% combined agreement. While all but one of the priorities exhibited at least a super-majority of agreement (>66.7% ‘agree’), 13 priorities had 90% combined agreement. Conclusions Adopting this multidisciplinary consensus-built research priorities agenda can deliver a step-change in addressing fatty liver disease, mitigating against its individual and societal harms and proactively altering its natural history through prevention, identification, treatment, and care. This agenda should catalyse the global health community’s efforts to advance and accelerate responses to this widespread and fast-growing public health threat. Impact and implications An estimated 38% of adults and 13% of children and adolescents worldwide have fatty liver disease, making it the most prevalent liver disease in history. Despite substantial scientific progress in the past three decades, the burden continues to grow, with an urgent need to advance understanding of how to prevent, manage, and treat the disease. Through a global consensus process, a multidisciplinary group agreed on 28 research priorities covering a broad range of themes, from disease burden, treatment, and health system responses to awareness and policy. The findings have relevance for clinical and non-clinical researchers as well as funders working on fatty liver disease and non-communicable diseases more broadly, setting out a prioritised, ranked research agenda for turning the tide on this fast-growing public health threat

Forest or meadow: the consequences of habitat on female arctic ground squirrel condition

Body condition of animals influences the likelihood of surviving harsh environmental conditions, successfully reproducing and resisting disease. The sum of these individual components of fitness, in turn, have consequences for the growth and persistence of wildlife populations. Here we compared the body mass and condition of adult female arctic ground squirrels, Urocitellus parryii (Richardson, 1825) (an obligate hibernator) in source and sink habitats. We tested the hypothesis that adult females would be in poorer condition in the boreal forest than in adjacent meadows. We found that, during spring, postpartum females in forests weighed less (405 ± 7g (SE) vs. 437 ± 11g) and were in poorer condition (mean residual of mass over structural size = -11.0 ± 10.2g vs. 20.5 ± 6.1g) compared to females in meadow source habitat. However, by the onset of entrance into hibernation in August, forest squirrels had reached parity with meadow squirrels and no difference was found in mass (519 ± 13g vs. 520 ± 15g) or condition (residual index = -0.01 ±0.01 vs. 0.03 ±0.01). We suggest that, for squirrels in formerly occupied boreal forests a) poor spring body condition decreased reproductive success, and b) achieving compensatory growth, via increased foraging, comes at the costs of higher predation risk. These costs likely contributed to the recent local extinction of AGS in boreal forest habitat.The accepted manuscript in pdf format is listed with the files at the bottom of this page. The presentation of the authors' names and (or) special characters in the title of the manuscript may differ slightly between what is listed on this page and what is listed in the pdf file of the accepted manuscript; that in the pdf file of the accepted manuscript is what was submitted by the author

Vibro-Acoustic Platelet Activation: An Additive Mechanism of Prothrombosis with Applicability to Snoring and Obstructive Sleep Apnea

Introduction: Obstructive sleep apnea (OSA) and loud snoring are conditions with increased cardiovascular risk and notably an association with stroke. Central in stroke are thrombosis and thromboembolism, all related to and initiaing with platelet activation. Platelet activation in OSA has been felt to be driven by biochemical and inflammatory means, including intermittent catecholamine exposure and transient hypoxia. We hypothesized that snore-associated acoustic vibration (SAAV) is an activator of platelets that synergizes with catecholamines and hypoxia to further amplify platelet activation. Methods: Gel-filtered human platelets were exposed to snoring utilizing a designed vibro-acoustic exposure device, varying the time and intensity of exposure and frequency content. Platelet activation was assessed via thrombin generation using the Platelet Activity State assay and scanning electron microscopy. Comparative activation induced by epinephrine and hypoxia were assessed individually as well as additively with SAAV, as well as the inhibitory effect of aspirin. Results: We demonstrate that snore-associated acoustic vibration is an independent activator of platelets, which is dependent upon the dose of exposure, i.e., intensity x time. In snoring, acoustic vibrations associated with low-frequency sound content (200 Hz) are more activating than those associated with high frequencies (900 Hz) (53.05% vs. 22.08%, p = 0.001). Furthermore, SAAV is additive to both catecholamines and hypoxia-mediated activation, inducing synergistic activation. Finally, aspirin, a known inhibitor of platelet activation, has no significant effect in limiting SAAV platelet activation. Conclusion: Snore-associated acoustic vibration is a mechanical means of platelet activation, which may drive prothrombosis and thrombotic risk clinically observed in loud snoring and OSA. © 2023 by the authors.Open access journalThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at [email protected]